- Home
- PYPD vs NVNI Comparison
PYPD vs NVNI Comparison
Compare PYPD & NVNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- NVNI
- Stock Information
- Founded
- PYPD 2008
- NVNI 2019
- Country
- PYPD Israel
- NVNI Brazil
- Employees
- PYPD N/A
- NVNI N/A
- Industry
- PYPD Medical/Dental Instruments
- NVNI
- Sector
- PYPD Health Care
- NVNI
- Exchange
- PYPD Nasdaq
- NVNI Nasdaq
- Market Cap
- PYPD 36.0M
- NVNI 31.5M
- IPO Year
- PYPD 2020
- NVNI N/A
- Fundamental
- Price
- PYPD $3.66
- NVNI $0.35
- Analyst Decision
- PYPD Strong Buy
- NVNI
- Analyst Count
- PYPD 5
- NVNI 0
- Target Price
- PYPD $11.40
- NVNI N/A
- AVG Volume (30 Days)
- PYPD 175.1K
- NVNI 1.2M
- Earning Date
- PYPD 08-13-2025
- NVNI 08-07-2025
- Dividend Yield
- PYPD N/A
- NVNI N/A
- EPS Growth
- PYPD N/A
- NVNI N/A
- EPS
- PYPD N/A
- NVNI N/A
- Revenue
- PYPD N/A
- NVNI $31,250,627.00
- Revenue This Year
- PYPD N/A
- NVNI $12.05
- Revenue Next Year
- PYPD N/A
- NVNI $15.02
- P/E Ratio
- PYPD N/A
- NVNI N/A
- Revenue Growth
- PYPD N/A
- NVNI 1491.58
- 52 Week Low
- PYPD $2.30
- NVNI $0.14
- 52 Week High
- PYPD $4.42
- NVNI $12.19
- Technical
- Relative Strength Index (RSI)
- PYPD 65.03
- NVNI 51.52
- Support Level
- PYPD $3.30
- NVNI $0.33
- Resistance Level
- PYPD $3.87
- NVNI $0.38
- Average True Range (ATR)
- PYPD 0.14
- NVNI 0.03
- MACD
- PYPD 0.01
- NVNI 0.01
- Stochastic Oscillator
- PYPD 86.84
- NVNI 65.10
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About NVNI Nvni Group Limited
Nvni Group Ltd is a holding company that conducts all of its business through Nuvini SA and Nuvini acquired companies. Nuvini S.A. acquires and operates software companies within SaaS markets in Brazil. Nuvini S.A. is the private serial software business acquirer in Brazil and intends to use funding and capital markets access to continue expanding its acquisition plans in Brazil and Latin America. The Company has determined that it has a single operating and reportable segment which is multi-vertical SaaS solution model.